Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
290,8 GBX | +1,31 % | +35,30 % | +32,23 % |
29/04 | El FTSE 100, pendiente de la decisión de la Fed sobre los tipos de interés | AN |
29/04 | Transcript : Oxford Biomedica plc, Q4 2023 Earnings Call, Apr 29, 2024 |
Resumen de negocios
Número de empleados: 714
Ventas por actividad
GBP en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Platform
99,9
%
| 143 | 99,9 % | 140 | 99,9 % | -1,96 % |
Product
0,1
%
| 0 | 0,1 % | 0 | 0,1 % | -17,31 % |
Ventas por región
GBP en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
44,0
%
| - | - | 62 | 44,0 % | - |
United Kingdom
35,7
%
| - | - | 50 | 35,7 % | - |
Europe
20,0
%
| 116 | 81,1 % | 28 | 20,0 % | -75,76 % |
Rest of World
0,3
%
| 27 | 18,9 % | 0 | 0,3 % | -98,54 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 27/03/23 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 29/08/17 |
Chairman | 68 | 24/06/20 | |
Nick Page
COO | Chief Operating Officer | - | 03/04/19 |
James Miskin
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/00 |
Matthew Treagus
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/21 |
Chief Tech/Sci/R&D Officer | - | 01/01/97 | |
Sophia Bolhassan
IRC | Investor Relations Contact | - | 01/10/21 |
Natalie Walter
IRO | Public Communications Contact | 50 | 01/05/19 |
Lisa James
HRO | Human Resources Officer | - | 01/01/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 01/05/23 |
Chairman | 68 | 24/06/20 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 01/06/16 |
Director/Board Member | 58 | 15/03/18 | |
Michael Hayden
BRD | Director/Board Member | 72 | 15/07/21 |
Dame Davies
BRD | Director/Board Member | 73 | 01/03/21 |
Frank Mathias
CEO | Chief Executive Officer | 62 | 27/03/23 |
Director/Board Member | 64 | 14/12/21 | |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 29/08/17 |
Namrata Patel
BRD | Director/Board Member | - | 13/04/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 100 000 296 | 80 810 643 ( 80,81 %) | 0 | 80,81 % |
Información de la empresa
Oxford Biomedica Plc
Windrush Court Transport Way
OX4 6LT, Oxford
+44 1865 783 000
http://www.oxfordbiomedica.co.ukSector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+32,23 % | 358 M | |
-1,17 % | 104 mil M | |
+2,87 % | 97,47 mil M | |
+4,43 % | 22,25 mil M | |
-14,77 % | 21,68 mil M | |
-9,10 % | 18,2 mil M | |
-39,98 % | 17,02 mil M | |
-13,21 % | 16,36 mil M | |
+8,55 % | 14,39 mil M | |
+35,75 % | 12,37 mil M |
- Bolsa de valores
- Acciones
- Acción OXB
- Empresa Oxford Biomedica plc